Newsfiscal.ai
Contineum Therapeutics, Inc. 12-Month Price Target Adjusted to $21.43
· Published
Article summary
Analysts have updated the 12-month price target for Contineum Therapeutics, Inc. to $21.43, reflecting a potential upside of approximately 121% based on the November 3, 2026, closing price.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…